Псориаз и психиатрическая коморбидность
- Авторы: Круглова Л.С1, Пушкина А.В1, Хотко А.А2
-
Учреждения:
- Центральная государственная медицинская академия
- Клинический кожно-венерологический диспансер
- Выпуск: Том 26, № 8 (2019)
- Страницы: 8-13
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/312438
- DOI: https://doi.org/10.18565/pharmateca.2019.8.8-12
- ID: 312438
Цитировать
Полный текст
![Открытый доступ](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Аннотация
Данная статья носит обзорный характер. Псориаз является хроническим заболеванием, влияющим на качество жизни пациентов. Это заболевание связано с повышенным риском возникновения коморбидных психических расстройств, которые могут быть не полностью распознаны врачом-дерматовенерологом в рамках амбулаторного приема. Крайне важно понять влияние этого заболевания на психическое здоровье и определить факторы риска, которые могут помочь в выявлении пациентов, подверженных психическим заболеваниям. Выявляя пациентов с псориазом высокого риска развития психиатрической патологии, дерматологи могут стремиться к оптимальному междисциплинарному лечению заболевания и таким образом помочь облегчить связанную с ним психиатрическую симптоматику.
Ключевые слова
Полный текст
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Об авторах
Л. С Круглова
Центральная государственная медицинская академияМосква, Россия
А. В Пушкина
Центральная государственная медицинская академия
Email: anyasawina@gmail.com
аспирант кафедры дерматовенерологии и косметологии Москва, Россия
А. А Хотко
Клинический кожно-венерологический диспансерКраснодар, Россия
Список литературы
- Menter A., Gottlieb A., Feldman S.R., et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826-50. Doi: 10.1016/j. jaad.2008.02.039.
- Kumar S., Kachhawha D., Das Koolwal G., et al. Psychiatric morbidity in psoriasis patients: a pilot study. Indian J Dermatol Venereol Leprol. 2011;77:625. doi: 10.4103/0378-6323.84074.
- Kimball A.B., Guerin A., Tsaneva M., et al. Economic burden of comorbidities in patients with psoriasis is substantial. J Eur Acad Dermatol Venereol. 2011;25(2):157-63. doi: 10.1111/j.1468-3083.2010.03730.x.
- Dauden E, Puig L., Ferrandiz C., et al. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol. 2016;30(2):1-18. doi: 10.1111/jdv.l3542.
- Palijan T.Z., Kovacevic D., Koic E., et al. The impact of psoriasis on the quality of life and psychological characteristics of persons suffering from psoriasis. CollAntropol. 2011;35(2):81-5.
- Richards H.L., Fortune D.G., Griffiths C.E., Main C.J. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50(1):11-5. doi: 10.1016/s0022-3999(00)00210-5.
- Evers A.W, Verhoeven E.W., Kraaimaat F.W., et al. How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol. 2010;163:986-91. doi: 10.1111/j.1365-2133.2010.09984.x.
- Moynihan J., Rieder E., Tausk F.Psychoneuroimmunology: the example of psoriasis. G Ital Dermatol Venereol. 2010;145:221-28.
- Hunter H.J., Griffiths C.E., Kleyn C.E. Does psychosocial stress play a role in the exacerbation of psoriasis? Br J Dermatol. 2013;169:965-74. doi: 10.1111/bjd.12478.
- Reich A., Hrehorow E., Szepietowski J.C. Pruritus is an important factor negatively influencing the wellbeing of psoriatic patients. Acta Derm Venereol. 2010;90:257-63. doi: 10.2340/000155550851.
- Heller M.M., Lee E.S., Koo J.Y. Stress as an influencing factor in psoriasis. Skin Therapy Lett. 2011;16:1-6.
- Jankovic S., Raznatovic M., Marinkovic J., et al. Relevance of psychosomatic factors in psoriasis: a case-control study. Acta Derm Venereol. 2009;89:364-68. doi: 10.2340/000155550669
- Dowlatshahi E.A., Wakkee M., Arends L.R., Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 20:4;:34(6)::542-5:. doi: 10.1038/jid.2013.508.
- Olfson M., Marcus S.C., Druss B., et al. National trends in the outpatient treatment of depression. JAMA. 2002;287(2):203-9. Doi: 10.1001/ jama.287.2.203.
- Esposito M., Saraceno R., Giunta A., et al. An Italian study on psoriasis and depression. Dermatology. 2006;212(2):123-27. doi: 10.1159/000090652.
- Schmitt J.M., Ford D.E. Role of depression in quality of life for patients with psoriasis. Dermatology. 2007;2:5(:)::7-27. doi: 10.1159/000102029.
- Fleming P, Roubille C., Richer V, et al. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2015;29(6):1063-70. Doi: 10.1111/ jdv. 12909.
- Kurd S.K., Troxel A.B., Crits-Christoph P., Gelfand J.M. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891-95. doi: 10.1001/archdermatol.2010.186.
- Gupta M.A., Gupta A.K. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4:833-doi: 10.2165/00128071-200304120 00003.
- Bougueon K., Misery L. Depression and psoriasis. Ann Dermatol Venereol. 2008;135(4):254-58. doi: 10.1016/S0151-9638(08)70544-1.
- Martin B., Sanchez-Carazo J.L., Perez-Ferriols A., et al. Clinical experience with etanercept in the treatment of psoriasis. Actas Dermosifiliogr. 2008;99:540-45.
- Rieder E., Tausk F Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol. 2012;51:12-26. doi: 10.1111/j.1365-4632.2011.05071.x.
- Gowda S., Goldblum O.M., McCall W.V., Feldman S.R. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol. 2010;63:114-23. doi: 10.1016/j.jaad.2009.07.003.
- Kannan S., Heller M.M., lee E.S., Koo J.Y The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know. J Dermatolog Treat. 2013;24:148-52. doi: 10.3109/09546634.2011.619159.
- Hagforsen E., Michaёlsson K., Lundgren E., et al. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study. Acta Derm Venereol. 2005;85: 225-32. doi: 10.1080/00015550510026587.
- Sandyk R., Pardeshi R. Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin. Int J Neurosci. 1990;50:215-21.
- Devrimci-Ozguven H., Kundakci T.N., Kumbasar H., et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14:267-71. doi: 10.1046/j.1468-3083.2000.00085.x.
- Kaufman K.R. Etanercept, anticytokines and mania. Int Clin Psychopharmacol. 2005;20:239-41. doi: 10.1097/00004850-200507000-00008
- Demirhan O., Demirbek B., Tunc E., et al. Identification of chromosome abnormalities in screening of a family with manic depression and psoriasis: predisposition to aneuploidy. Asian J Psychiatr. 2012;5:169-74. Doi: 10.1016/j. ajp.2012.02.005.
- Basavaraj K.H., Navya M.A., Rashmi R. Stress and quality of life in psoriasis: an update. Int J Dermatol. 2011;50:783-92. doi: 10.1111/j.1365-4632.2010.04844.x.
- Crosta M.L., Caldarola G., Fraietta S., et al. Psychopathology and eating disorders in patients with psoriasis. G Ital Dermatol Venereol. 2014;149:355-61.
- Kotrulja L., Tadinac M., Joki-Begi N.A., Gregurek R. A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients. Acta Derm Venereol. 2010;90:251-56. doi: 10.2340/000155550838.
- Yang Y.W., Lin H.C. Increased risk of psoriasis among patients with schizophrenia: a nationwide population-based study. Br J Dermatol. 2012;166:899-900. doi: 10.1111/j.1365-2133.2011.10684.x.
- Miyaoka T., Seno H., Inagaki T., et al. Schizophrenia associated with psoriasis vulgaris: three case reports. Schizophr Res. 2000;41:383-86.
- Latini A., Carducci M. Psoriasis during therapy with olanzapine. Eur J Dermatol. 2003;13:404-5.
- Ascari-Raccagni A., Baldari U., Rossi E., Alessandrini F. Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy. J Eur Acad Dermatol Venereol. 2000;14:315-16. doi: 10.1046/j.1468-3083.2000.00056-3.x
- Di Nuzzo S., Zanni M., De Panfilis G. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A but not with etanercept. J Drugs Dermatol. 2007;6: 1046-47.
- Callis Duffin K., Wong B., Horn E.J., Krueger G.G. Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol. 2009;60:604-8. Doi: 10.1016/j. jaad.2008.10.059.
- Shutty B.G., West C., Huang K.E., et al. Sleep disturbances in psoriasis. Dermatol Online J. 2013;19:1.
- Picardi A., Pasquini P, Cattaruzza M.S., et al. Only limited support for a role of psychosomatic factors in psoriasis. Results from a case-control study. J Psychosom Res. 2003;55:189-96. Doi: 10.1016/ s0022-3999(02)00574-3
- Poikolainen K., Reunala T., Karvonen J., et al. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ. 1990;300:780-783. doi: 10.1136/bmj.300.6727.780.
- Bahmer J.A., Kuhl J., Bahmer F.A. How do personality systems interact in patients with psoriasis, atopic dermatitis and urticaria? Acta Derm Venereol. 2007;87:317-24. doi: 10.2340/000155550246.
- Meyer N., Viraben R., Paul C. Addictions and psoriasis: an example of the dermatologist's implication in preventive medicine? Ann Dermatol Venereol. 2008;135(4):259-62. Doi: 10.1016/ S0151-9638(08)70545-3.
- Naldi L., Chatenoud L., Linder D., et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61-7. doi: 10.1111/j.0022-202X.2005.23681.x.
- Adamzik K., McAleer M.A., Kirby B. Alcohol and psoriasis: sobering thoughts. Clin Exp Dermatol. 2013;38:819-22. doi: 10.1111/ced.12013.
- Dediol I., Buljan M., Buljan D., et al. Association of psoriasis and alcoholism: psychodermatological issue. Psychiatr Danub. 2009;21:9-13.
Дополнительные файлы
![](/img/style/loading.gif)